Search CROs

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Full-service CRO providing clinical trial management, regulatory consulting, pharmacovigilance, biostatistics, and medical writing across 40+ countries with AI-secure eClinical systems and patient-centered trial design.

• Computational & In-Silico Drug Discovery
• Discovery Research
• GLP Toxicology

ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.

• Analytical Method Development & Validation
• Bioanalysis
• GLP Toxicology

BioQual Solutions provides reliable bioanalytical method development and LC-MS/MS expertise for small-molecule drug projects, from discovery through GLP validation.

• In Vivo Efficacy Models
• In Vivo PK / PD Studies
• Preclinical In Vivo Studies

Boston-area preclinical CRO specializing in non-GLP PK/PD and early toxicology studies in rodent and large animal models, including primates. AAALAC accredited with extensive vivarium capacity and multidisciplinary scientific support.

• Analytical Method Development & Validation
• Biostatistics & Statistical Programming
• Clinical Operations

Atheln provides customized strategic and operational consulting across product development, CMC, nonclinical, clinical, regulatory, and commercial services for pharma, biotech, and medtech clients.

• Bioanalysis
• Bioinformatics & Data Science
• Biomarker Assays

Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.

• Bioanalysis
• Biostatistics & Statistical Programming
• Clinical Operations

Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs.

• Bioanalysis
• Biostatistics & Statistical Programming
• Clinical Operations

Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

• Analytical Method Development & Validation
• Computational & In-Silico Drug Discovery
• Discovery Research

PI Health Sciences is an integrated CRDMO offering end-to-end drug discovery, development, and manufacturing services with R&D and manufacturing locations in Europe and India.

• Discovery Research
• Translational Research
• Biologics (Monoclonal Antibodies)

Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.

• Analytical Method Development & Validation
• Bioanalysis
• Computational & In-Silico Drug Discovery

Proone Labs provides preclinical pharmacology, drug discovery, and regulatory support services to biotech startups, traditional pharma, and in-silico companies. The team has delivered 30+ assays, 50+ cell lines, and supported 4 FDA drug approvals across multiple therapeutic areas.

• Analytical Method Development & Validation
• ICH Stability Studies
• Translational Research

Tioga Research specializes in topical and transdermal formulation development, combining proprietary Cascade Screening™ methodology with high-throughput excipient screening and in vitro skin permeation testing for pharmaceutical and cosmetic clients.

• Computational & In-Silico Drug Discovery
• Discovery Research
• High-Throughput Screening

Synfini provides AI-driven drug discovery services from target selection through lead optimization, combining cloud-based AI design tools with robotic wet lab automation to accelerate DMTA cycles across diverse chemical modalities and therapeutic indications.

• Discovery Research
• GLP Toxicology
• Medicinal Chemistry

R2M Pharma is a medicinal chemistry CRO specializing in small-molecule drug discovery and preclinical development, from hit validation through GLP toxicology studies.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Selvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.

• Analytical Method Development & Validation
• Phase I Clinical Trials
• Phase II Clinical Trials

ReechPharma specializes in customized formulation development and drug delivery systems for preclinical and clinical stages, supporting biotech and pharma companies with formulation research, analytical services, and GMP manufacturing.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.